These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

324 related items for PubMed ID: 22964399

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3. Humidity-induced changes of the aerodynamic properties of dry powder aerosol formulations containing different carriers.
    Zeng XM, MacRitchie HB, Marriott C, Martin GP.
    Int J Pharm; 2007 Mar 21; 333(1-2):45-55. PubMed ID: 17064863
    [Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7. Evaluation of Granulated Lactose as a Carrier for Dry Powder Inhaler Formulations 2: Effect of Drugs and Drug Loading.
    Du P, Du J, Smyth HDC.
    J Pharm Sci; 2017 Jan 21; 106(1):366-376. PubMed ID: 27939234
    [Abstract] [Full Text] [Related]

  • 8. Insights into the roles of carrier microstructure in adhesive/carrier-based dry powder inhalation mixtures: Carrier porosity and fine particle content.
    Shalash AO, Molokhia AM, Elsayed MM.
    Eur J Pharm Biopharm; 2015 Oct 21; 96():291-303. PubMed ID: 26275831
    [Abstract] [Full Text] [Related]

  • 9. Dry powder inhaler performance of spray dried mannitol with tailored surface morphologies as carrier and salbutamol sulphate.
    Mönckedieck M, Kamplade J, Fakner P, Urbanetz NA, Walzel P, Steckel H, Scherließ R.
    Int J Pharm; 2017 May 30; 524(1-2):351-363. PubMed ID: 28347847
    [Abstract] [Full Text] [Related]

  • 10. Preparation and Evaluation of Surface Modified Lactose Particles for Improved Performance of Fluticasone Propionate Dry Powder Inhaler.
    Singh DJ, Jain RR, Soni PS, Abdul S, Darshana H, Gaikwad RV, Menon MD.
    J Aerosol Med Pulm Drug Deliv; 2015 Aug 30; 28(4):254-67. PubMed ID: 25517187
    [Abstract] [Full Text] [Related]

  • 11. Surface Modification of lactose carrier particles using a fluid bed coater to improve fine particle fraction for dry powder inhalers.
    Gong QQ, Tay JYS, Veronica N, Xu J, Heng PWS, Zhang YP, Liew CV.
    Pharm Dev Technol; 2023 Feb 30; 28(2):164-175. PubMed ID: 36683577
    [Abstract] [Full Text] [Related]

  • 12. Role of dispersion enhancer selection in the development of novel tratinterol hydrochloride dry powder inhalation formulations.
    Liu T, Tong S, Liao Q, Pan L, Cheng M, Rantanen J, Cun D, Yang M.
    Int J Pharm; 2023 Mar 25; 635():122702. PubMed ID: 36773729
    [Abstract] [Full Text] [Related]

  • 13. What is the role of particle morphology in pharmaceutical powder aerosols?
    Chan HK.
    Expert Opin Drug Deliv; 2008 Aug 25; 5(8):909-14. PubMed ID: 18712999
    [Abstract] [Full Text] [Related]

  • 14. The influence of drug morphology on aerosolisation efficiency of dry powder inhaler formulations.
    Adi H, Traini D, Chan HK, Young PM.
    J Pharm Sci; 2008 Jul 25; 97(7):2780-8. PubMed ID: 17894369
    [Abstract] [Full Text] [Related]

  • 15. Does carrier size matter? A fundamental study of drug aerosolisation from carrier based dry powder inhalation systems.
    Ooi J, Traini D, Hoe S, Wong W, Young PM.
    Int J Pharm; 2011 Jul 15; 413(1-2):1-9. PubMed ID: 21501674
    [Abstract] [Full Text] [Related]

  • 16. Characterizing the Surface Roughness Length Scales of Lactose Carrier Particles in Dry Powder Inhalers.
    Tan BMJ, Chan LW, Heng PWS.
    Mol Pharm; 2018 Apr 02; 15(4):1635-1642. PubMed ID: 29490144
    [Abstract] [Full Text] [Related]

  • 17. Critical attributes of fine excipient materials in carrier-based dry powder inhalation formulations: The particle shape and surface properties.
    Elsayed MMA, Alfagih IM, Brockbank K, Aodah AH, Ali R, Almansour K, Shalash AO.
    Int J Pharm; 2024 Apr 25; 655():123966. PubMed ID: 38452834
    [Abstract] [Full Text] [Related]

  • 18. The role of lactose carrier on the powder behavior and aerodynamic performance of bosentan microparticles for dry powder inhalation.
    Lee HJ, Lee HG, Kwon YB, Kim JY, Rhee YS, Chon J, Park ES, Kim DW, Park CW.
    Eur J Pharm Sci; 2018 May 30; 117():279-289. PubMed ID: 29510172
    [Abstract] [Full Text] [Related]

  • 19. Lactose characteristics and the generation of the aerosol.
    Pilcer G, Wauthoz N, Amighi K.
    Adv Drug Deliv Rev; 2012 Mar 15; 64(3):233-56. PubMed ID: 21616107
    [Abstract] [Full Text] [Related]

  • 20. Evaluation of SCF-engineered particle-based lactose blends in passive dry powder inhalers.
    Schiavone H, Palakodaty S, Clark A, York P, Tzannis ST.
    Int J Pharm; 2004 Aug 20; 281(1-2):55-66. PubMed ID: 15288343
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 17.